Position in DXCM
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$23,679,619
New position
Shares Held
377,064
first reported quarter
Ownership
0.098%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 99.77696094031782.ToString("F0")%
Shared 0.ToString("F0")%
None 0.22303905968217597.ToString("F0")%
Position in Medical Devices
Healthcare · as of Mar 31, 2026SEB Asset Management AB holds $502,431,546 across 10 Medical Devices names. DXCM ranks #8 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
2,076,524 | $130,301,881 | |
| 2 | EW |
Edwards Lifesciences Corp
|
1,370,202 | $109,725,776 | |
| 3 | SYK |
Stryker Corp
|
263,366 | $86,539,433 | |
| 4 | ABT |
Abbott Laboratories
|
492,081 | $50,521,956 | |
| 5 | MDT |
Medtronic plc
|
419,352 | $36,336,850 | |
| 6 | STE |
STERIS plc
|
138,652 | $30,660,116 | |
| 7 | PODD |
Insulet Corp
|
117,711 | $24,700,476 | |
| 8 | DXCM |
Dexcom Inc
This page
|
377,064 | $23,679,619 |
All Filings in DXCM
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,679,619 | 377,064 | Shares | Sole | 2026-05-07 | |
| No filing history on record for this holder in this stock. | ||||||